These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8354909)

  • 21. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents.
    Brandt CM; Rouse MS; Laue NW; Stratton CW; Wilson WR; Steckelberg JM
    J Infect Dis; 1996 Apr; 173(4):909-13. PubMed ID: 8603970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS; Pitsakis PG; Zausner A; Livornese LL; Osborne AJ; Johnson CC; Levison ME
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2069-73. PubMed ID: 8257125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.
    Quale JM; Landman D; Mobarakai N
    J Antimicrob Chemother; 1994 Nov; 34(5):797-802. PubMed ID: 7706176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis.
    Lefort A; Saleh-Mghir A; Garry L; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3017-21. PubMed ID: 11036016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocarditis due to high level gentamicin resistant Enterococcus faecium.
    Das SS; Anderson JR; Macdonald AA; Somerville KW
    J Infect; 1994 Mar; 28(2):185-91. PubMed ID: 8034999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J; Perri MB; Thal LA; Donabedian SA; Zervos MJ
    J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillin resistance and aminoglycoside-penicillin synergy in enterococci.
    Lopardo HA; Venuta ME; Rubeglio EA
    Chemotherapy; 1995; 41(3):165-71. PubMed ID: 7656661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.
    Shlaes DM; Etter L; Gutmann L
    Antimicrob Agents Chemother; 1991 Apr; 35(4):776-9. PubMed ID: 2069388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    Reissier S; Saleh-Mghir A; Guerin F; Massias L; Ghout I; Sinel C; Cattoir V; Cremieux AC
    J Antimicrob Chemother; 2018 Apr; 73(4):981-986. PubMed ID: 29329389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.
    Pontikis K; Pefanis A; Tsaganos T; Tzepi IM; Carrer DP; Giamarellou H
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3392-4. PubMed ID: 23587961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of using relapse studies or tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective.
    Caron F
    J Infect Dis; 1997 Jan; 175(1):232-3. PubMed ID: 8985229
    [No Abstract]   [Full Text] [Related]  

  • 36. Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
    Schwank S; Blaser J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2258-61. PubMed ID: 8891125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
    Thompson RL; Lavin B; Talbot GH
    South Med J; 2003 Aug; 96(8):818-20. PubMed ID: 14515928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
    Matsumura S; Simor AE
    Clin Infect Dis; 1998 Dec; 27(6):1554-6. PubMed ID: 9868693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.